“Epidermal Growth Factor Polymorphism Most Prevalent in Stage II Cervical Carcinoma”. Universa Medicina, vol. 33, no. 3, Dec. 2014, pp. 192-8, https://doi.org/10.18051/UnivMed.2014.v33.192-198.